Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP325585.RARmbd0toIT-o0j-YU-t6KntXohJ_Wcgv20ak0jw-UjkY130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325585.RARmbd0toIT-o0j-YU-t6KntXohJ_Wcgv20ak0jw-UjkY130_provenance.
• NP450988.RAZQ6t8uWPDpx4k2D4UubKNGknd4VjYLoaaylFCW-Ccbs130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450988.RAZQ6t8uWPDpx4k2D4UubKNGknd4VjYLoaaylFCW-Ccbs130_provenance.
• NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661861.RAZN4eyjfs_jzIBimpNS6icUctEtKRdD0yZ0q_FA1dCHs130_provenance.
• NP827433.RAl8ALj63tNS5HtFVpPIxAonvhs4ZISyJOfwMlBBzs7lA130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827433.RAl8ALj63tNS5HtFVpPIxAonvhs4ZISyJOfwMlBBzs7lA130_provenance.
• NP523225.RAf1X9pGzUkuFeZo703zSfsJ9UlaM95efuun9GA8XKvsM130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523225.RAf1X9pGzUkuFeZo703zSfsJ9UlaM95efuun9GA8XKvsM130_provenance.
• NP879300.RAUj79zz7t5caEIpSzuWLmaUnceqwVhlvC25rYr08Xi2Q130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879300.RAUj79zz7t5caEIpSzuWLmaUnceqwVhlvC25rYr08Xi2Q130_provenance.
• NP554088.RA3PTdTVmqOPqBbXWDdgladECeHPf6MSLbbj62jeN9b3s130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554088.RA3PTdTVmqOPqBbXWDdgladECeHPf6MSLbbj62jeN9b3s130_provenance.
• NP886198.RAxFxFTvGIzI_gYvSbzYmenkxJtsh1PZvP8lWytUdaSmI130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886198.RAxFxFTvGIzI_gYvSbzYmenkxJtsh1PZvP8lWytUdaSmI130_provenance.
• NP919607.RA31try85mDoMu3dA13LWd2iCzrQt2_MSY6Fxdw4pIjG8130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919607.RA31try85mDoMu3dA13LWd2iCzrQt2_MSY6Fxdw4pIjG8130_provenance.
• assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP761547.RAu7n2lxKKxUOqMtha0jO9zycu1ORLGHgV_0fvB4JtFU8130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761547.RAu7n2lxKKxUOqMtha0jO9zycu1ORLGHgV_0fvB4JtFU8130_provenance.
• NP761583.RApx0lf78pXVIcIaNhvDIz0h0rFjv9hV1pJK8KEAAU8OQ130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761583.RApx0lf78pXVIcIaNhvDIz0h0rFjv9hV1pJK8KEAAU8OQ130_provenance.
• NP761661.RAAXWWJieIOkJS_vontNEyP_VrVCy0ZmXw6UcfAEteDsA130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761661.RAAXWWJieIOkJS_vontNEyP_VrVCy0ZmXw6UcfAEteDsA130_provenance.
• NP1067596.RAuccN5iKfB4Q_VggImjU-sC8Iu4aJmgtD2z9M1YYr_RI130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067596.RAuccN5iKfB4Q_VggImjU-sC8Iu4aJmgtD2z9M1YYr_RI130_provenance.
• NP1067598.RAvHXp2tBPcm3AIEA0x9ATlNkz6wQmB231hIOHPtRz5hI130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067598.RAvHXp2tBPcm3AIEA0x9ATlNkz6wQmB231hIOHPtRz5hI130_provenance.
• NP1067599.RAlGAcjXh1v9XwrWI5OFazsF5ktVZWbixwoYZVuBbFXI8130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067599.RAlGAcjXh1v9XwrWI5OFazsF5ktVZWbixwoYZVuBbFXI8130_provenance.
• NP1067600.RAmIw6hIFXHlitYbGBbqckA-TeJAk9o2viVeDxEiTT36c130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067600.RAmIw6hIFXHlitYbGBbqckA-TeJAk9o2viVeDxEiTT36c130_provenance.
• NP761568.RAFkTEdLPnL__kbNPc6OGdhFEZIfw38R7JHJkaOqYhhB8130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761568.RAFkTEdLPnL__kbNPc6OGdhFEZIfw38R7JHJkaOqYhhB8130_provenance.
• NP1067597.RAGW7INVqxlXUTcc8pBuzvxhVPFjBAoke6iIpZ7H6BlUk130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067597.RAGW7INVqxlXUTcc8pBuzvxhVPFjBAoke6iIpZ7H6BlUk130_provenance.
• NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761545.RA6lIgSReagPrp2-nKC19jdY6l1ePjolJHvUAdp5au7kA130_provenance.
• NP761897.RAyh-hVjmS7QCn2B1nTMBP_gLoj94jiVvf23L5zTEEias130_assertion description "[They detected intense immunoreactivity for TTR at high dilutions of primary antiserum in the neoplastic epithelium of all of nine primary CP tumors (six papillomas and three carcinomas), but not in eight cellular or three papillary intracerebral ependymomas, meningiomas, oligodendrogliomas, astrocytomas, primary extracerebral papillary carcinomas (three thyroid, two breast) or five of six cerebral metastases from systemic papillary carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761897.RAyh-hVjmS7QCn2B1nTMBP_gLoj94jiVvf23L5zTEEias130_provenance.